It could also explain why the primary trial endpoints did not reach statistical significance (GISSI-STATIN and VEST trials).
← all excerpts
Death without Previous Hospital Readmission in Patients with Heart Failure with Reduced Ejection Fraction-A New Endpoint from Old Clinical Trials.
1
—
—